183
Participants
Start Date
September 30, 2005
Primary Completion Date
November 30, 2008
Study Completion Date
November 30, 2008
Abatacept
Injectable, intravenous, 10 mg/kg, abatacept every 28 days, 12 months
Placebo
Injectable, intravenous, 0 mg, every 28 days, 12 months
Prednisone
Tablets, oral, 30 mg, daily for 28 days then taper off, 12 months
Abatacept
Injectable, intravenous, 10 mg/kg, every 28 days
Local Institution, Taipei
Local Institution, Taichung
Local Institution, Kaohsiung City
Local Institution, Brussels
Local Institution, Leuven
Local Institution, Heidelberg
Local Institution, Malvern
Local Institution, Clayton
Local Institution, Berea
Local Institution, Maroochydore
Local Institution, Cairns
Local Institution, Panorama
Local Institution, Graz
Columbia University Medical Center, New York
Suny Downstate Medical Center, Brooklyn
Local Institution, Taipei
Local Institution, Campinas
Local Institution, Berlin
Local Institution, Aguascalientes
Local Institution, Rio de Janeiro - Rj
Local Institution, Bordeaux
Cria Research, Fort Lauderdale
Local Institution, Montpellier
Kentuckiana Center For Better Bone And Joint Health, Louisville
Local Institution, Düsseldorf
Local Institution, Ferrara
Local Institution, Morelia
The University Of Chicago, Chicago
Ok Medical Research Foundations, Oklahoma City
Local Institution, Goiânia
Local Institution, Paris
Texas Research Center, Sugarland
Local Institution, Freiburg im Breisgau
Local Institution, Curitiba
Denver Arthritis Clinic, Denver
University Of Arizona Arthritis Center, Tucson
Kelly, Timothy, Las Vegas
8737 Beverly Blvd., Los Angeles
Office Of Geoffrey S. Dolan, Md, Long Beach
Local Institution, São Paulo
Local Institution, São Paulo
Local Institution, São Paulo
Local Institution, São Paulo
Local Institution, Vancouver
Local Institution, Winnipeg
Local Institution, Mexico City
Local Institution, Ponce
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Seoul
Local Institution, London
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY